| Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label … L Paz-Ares, M Dvorkin, Y Chen, N Reinmuth, K Hotta, D Trukhin, ... The Lancet 394 (10212), 1929-1939, 2019 | 1526 | 2019 |
| COPD in never smokers: results from the population-based burden of obstructive lung disease study B Lamprecht, MA McBurnie, WM Vollmer, G Gudmundsson, T Welte, ... Chest 139 (4), 752-763, 2011 | 827 | 2011 |
| Determinants of underdiagnosis of COPD in national and international surveys B Lamprecht, JB Soriano, M Studnicka, B Kaiser, LE Vanfleteren, ... Chest 148 (4), 971-985, 2015 | 448 | 2015 |
| Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN … JW Goldman, M Dvorkin, Y Chen, N Reinmuth, K Hotta, D Trukhin, ... The Lancet Oncology 22 (1), 51-65, 2021 | 429 | 2021 |
| Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled … F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, J Poissy, ... The Lancet infectious diseases 22 (2), 209-221, 2022 | 343 | 2022 |
| Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke: the global COVID-19 stroke registry G Ntaios, P Michel, G Georgiopoulos, Y Guo, W Li, J Xiong, P Calleja, ... Stroke 51 (9), e254-e258, 2020 | 332 | 2020 |
| Electromagnetic navigation bronchoscopy for peripheral pulmonary lesions: one-year results of the prospective, multicenter NAVIGATE study EE Folch, MA Pritchett, MA Nead, MR Bowling, SD Murgu, WS Krimsky, ... Journal of Thoracic Oncology 14 (3), 445-458, 2019 | 303 | 2019 |
| COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) study L Schirnhofer, B Lamprecht, WM Vollmer, MJ Allison, M Studnicka, ... Chest 131 (1), 29-36, 2007 | 292 | 2007 |
| Virus-induced senescence is a driver and therapeutic target in COVID-19 S Lee, Y Yu, J Trimpert, F Benthani, M Mairhofer, P Richter-Pechanska, ... Nature 599 (7884), 283-289, 2021 | 231 | 2021 |
| Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data JB Soriano, B Lamprecht, AS Ramírez, P Martinez-Camblor, B Kaiser, ... The Lancet Respiratory medicine 3 (6), 443-450, 2015 | 204 | 2015 |
| Predictors of dyspnoea prevalence: results from the BOLD study R Grønseth, WM Vollmer, JA Hardie, IS Ólafsdóttir, B Lamprecht, AS Buist, ... European Respiratory Journal 43 (6), 1610-1620, 2014 | 146 | 2014 |
| Electromagnetic navigation bronchoscopy (ENB): Increasing diagnostic yield B Lamprecht, P Porsch, B Wegleitner, G Strasser, B Kaiser, M Studnicka Respiratory medicine 106 (5), 710-715, 2012 | 119 | 2012 |
| Prevalence and burden of chronic bronchitis symptoms: results from the BOLD study F Mejza, L Gnatiuc, AS Buist, WM Vollmer, B Lamprecht, DO Obaseki, ... European Respiratory Journal 50 (5), 2017 | 118 | 2017 |
| Electromagnetic navigation bronchoscopy in combination with PET-CT and rapid on-site cytopathologic examination for diagnosis of peripheral lung lesions B Lamprecht, P Porsch, C Pirich, M Studnicka Lung 187, 55-59, 2009 | 116 | 2009 |
| Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study WC Tan, WM Vollmer, B Lamprecht, DM Mannino, A Jithoo, ... Thorax 67 (8), 718-726, 2012 | 110 | 2012 |
| Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD) M Humenberger, A Horner, A Labek, B Kaiser, R Frechinger, C Brock, ... BMC pulmonary medicine 18, 1-6, 2018 | 83 | 2018 |
| Farming and the prevalence of non‐reversible airways obstruction—results from a population‐based study B Lamprecht, L Schirnhofer, B Kaiser, M Studnicka, AS Buist American journal of industrial medicine 50 (6), 421-426, 2007 | 82 | 2007 |
| Chronic obstructive pulmonary disease: a worldwide problem JB Soriano, B Lamprecht Medical Clinics 96 (4), 671-680, 2012 | 79 | 2012 |
| Overdiagnosis of COPD in subjects with unobstructed spirometry: a BOLD analysis L Sator, A Horner, M Studnicka, B Lamprecht, B Kaiser, MA McBurnie, ... Chest 156 (2), 277-288, 2019 | 75 | 2019 |
| A simple algorithm for the identification of clinical COPD phenotypes PR Burgel, JL Paillasseur, W Janssens, J Piquet, G Ter Riet, ... European Respiratory Journal 50 (5), 2017 | 74 | 2017 |
Michael StudnickaProfessor für Pneumologie, PMU SalzburgVerifierad e-postadress på salk.at
